Stock Events

CASI Pharmaceuticals (CASI) Q3 2024 Earnings

CASI +0.56%
16AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.71
-0.49
-0.27
-0.05

Details

Expected EPS
-0.63
Actual EPS
-0.52
Surprise EPS
0.11
Surprise Percent
+17.46%

Description

CASI Pharmaceuticals (CASI) has reported earnings of -0.52 per share for Q3 2024.

0 Comments

Share your thoughts